12 Amendments of Jan-Christoph OETJEN related to 2021/2007(INI)
Amendment 2 #
Draft opinion
Paragraph 1
Paragraph 1
1. Welcomes the communication on an intellectual property action plan to support the EU’s recovery and resilience, but regrets that the focus on international cooperation and assistance to developing countries is poorly addressed; in this regard, calls on the EU to assume the role of a key global player in the field of intellectual property and to lead international efforts in order to accelerate and facilitate the sustainable development of low and middle income countries;
Amendment 5 #
Draft opinion
Paragraph 2
Paragraph 2
2. Calls on the Commission to continue strengthening intellectual property rights (IPR) protection and enforcement in non-EU countries through EU-funded technical cooperation programmes; in this context, encourages the Commission, on the basis of the EU’s experience, to assist and provide policy makers and enforcement authorities with knowledge and guidelines for improving the capacity to tackle infringements of IPR, and to promote feasible solutions, which could significantly reduce costs and simplify the procedures for obtaining, maintaining and enforcing the protection of IPRs, as well as to give information to rights holders about the changing infringement landscape and the supply of counterfeit goods; welcomes in particular the intention to promote better generation and management of intellectual property (IP) on the African continent as part of a joint partnership building on the current four- year cooperation programme for Africa;
Amendment 10 #
Draft opinion
Paragraph 2 a (new)
Paragraph 2 a (new)
2 a. Considers that IPR is a key factor in promoting economic development, through which innovators and investors can encourage domestic innovation and attract foreign direct investment; in that regard, believes that IPR can strengthen economic advancement in developing countries by offering means to participate in global economic activities and by strengthening exports of local products;
Amendment 11 #
Draft opinion
Paragraph 2 a (new)
Paragraph 2 a (new)
2 a. Points out that SMEs ought to be able to take full advantage of their technology and innovative products, processes or methods; underlines the importance of protecting IPRs, since infringements lead to losses for citizens and producers – such as loss of jobs, sales, or tax revenue - and could inflict serious damage and pose risks to the health and safety of consumers;
Amendment 13 #
Draft opinion
Paragraph 2 b (new)
Paragraph 2 b (new)
Amendment 16 #
Draft opinion
Paragraph 3
Paragraph 3
3. Strongly encourages the Commission to assist producers and their associations as well as local authorities in developing countries in unlocking the potential of IP and reaping the economic value of local innovations, geographical indications and traditional knowledge; reiterates its call, in this regard, to respect the progress achieved in the international protection of indigenous peoples’ rights over their genetic resources and associated traditional knowledge; calls on the Commission to increase efforts to offer qualified consulting services with the purpose to help innovative enterprises at the different stages of the research and innovation process, as well as to provide technical assistance and raise awareness as to the significance of the new opportunities which new technologies and digital means offer, since a well functioning IP framework is of utmost importance for growth and competitiveness;
Amendment 25 #
Draft opinion
Paragraph 4
Paragraph 4
4. Recognises that IP systems contribute to the development of new medicines, but stresses that they must comply with international human rights law and public health requirements; notesacknowledges that IP systems are needed, as through them it is possible to search for, design and disseminate viable solutions and mechanisms for prevention and for building resilience to health related issues, and that such systems contribute to strengthening abilities for instigating positive change and progress; notes, however, that strong IPRs may in some cases limit access to medicines in developing countries while not necessarily encouraging pharmaceutical innovation that responds to the needs of developing and least developed countries;
Amendment 27 #
Draft opinion
Paragraph 4
Paragraph 4
4. Recognises that IP systems contribute to the development of new medicines, but stresses that they must comply with international human rights law and public health requirements; notes that strong IPRs may limit access to medicines in developing countries while not necessarily encouraging pharmaceutical innovation that responds to the needs of developing countriesintellectual property protection is an enabler for global production and distribution of vaccines and other medicines, as well as research, development and innovation, and that intellectual property protection creates an environment of trust for producers and investors, as well as long-term certainty;
Amendment 39 #
Draft opinion
Paragraph 5
Paragraph 5
5. Welcomes, as a positive step,Notes the recently announced US support for a proposal to temporarily waive certain provisions of the Agreement on Trade- Related Aspects of Intellectual Property Rights for the prevention, containment and treatment of COVID-19; urges the Commission, therefore, to follow through on its promise to engage in active and constructive text-based negotiations at World Trade Organization level.supports the EU in their discussions within the WTO on flexibilities within the TRIPS agreement; calls in this regard for a thorough analysis on how to apply and successfully implement article 31bis of the TRIPS Agreement and enable exporting licenses to countries that cannot satisfy domestic demand;
Amendment 40 #
Draft opinion
Paragraph 5
Paragraph 5
5. Welcomes, as a positive step, the recently announced US support for a proposal to temporarily waive certain provisions of the Agreement on Trade- Related Aspects of Intellectual Property Rights for the prevention, containment and treatment of COVID-19; urges the CommisNotes the recently announced United States’ support for waiving intellectual property protections for COVID-19 vaccines; in this light, recalls the Commission’s statement that the EU is ready to conduct discussions on the possible impacts of a temporary waiver of TRIPS provisions, therefore, to follow through on its promise to engage in activeand that overcoming the world's production difficulties, as well as investments and constructive text-based negotiations at World Trade Organization level.ibutions to the COVAX system are key priorities for expanding the global access to vaccines;
Amendment 43 #
Draft opinion
Paragraph 5 a (new)
Paragraph 5 a (new)
5 a. Notes that any decision taken within the existing framework should be conditional on the effective ramping up of global production capacity, ensuring that vaccines are fairly and evenly distributed through the removal of trade barriers on exports of vaccines, by encouraging voluntary licensing and sharing of know- how of leading pharmaceutical companies;
Amendment 47 #
Draft opinion
Paragraph 5 b (new)
Paragraph 5 b (new)
5 b. Urges the Commission to maintain its strong support for innovation and intellectual property rights in global discussions;